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SUMMARY
Introduction. Prolonged survival of patients under HAART has resulted in new demands for assisted reproductive technologies.
HIV serodiscordant couples wish to make use of assisted reproduction techniques in order to avoid viral transmission to the
partner or to the newborn. It is therefore essential to test the effectiveness of techniques aimed at reducing HIV and HCV loads in
infected semen using molecular biology tests.
Methods. After seminal analysis, semen samples from 20 coinfected patients were submitted to cell fractioning and isolation
of motile spermatozoa by density gradient centrifugation and swim-up.  HIV and HCV RNA detection tests were performed with
RNA obtained from sperm, seminal plasma and total semen.
Results. In pre-washing semen, HIV RNA was detected in 100% of total semen samples, whereas HCV RNA was concomitantly
amplified in only one specimen. Neither HIV nor HCV were detected either in the swim-up or in the post-washing semen fractions.
Conclusions. Reduction of HIV and/or HCV shedding in semen by density gradient centrifugation followed by swim-up is an
efficient method. These findings lead us to believe that, although semen is rarely found to contain HCV, semen processing is
highly beneficial for HIV/HCV coinfected individuals.
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INTRODUCTION
According to current figures in the Brazilian Epidemiological
Reports (www.aids.gov.br), there are 600,000 HIV-infected people in
Brazil, of whom 65% are males of sexually active age. Also worthy of
note is the growing proportion of Brazilians (17.7% to 36.2%) who
are also infected with the hepatitis C virus (HCV)25,40. This coinfection
is an important factor in the natural history of AIDS and contributes to
greater morbidity and mortality in these patients. Furthermore,
prolonged survival of patients under HAART (Highly Active
Antiretroviral Therapy) has given rise to a new demand from
serodiscordant couples who wish to have children. As these couples
cannot stop using condoms, lest they infect their seronegative partner
or the newborn, it is essential to treat the infected semen with effective
laboratory techniques that not only isolate the best spermatozoa, but
also remove HIV and HCV infected cells from the semen.
This is achieved in many studies by using the semen washing
technique together with the swim up26 method to purify the infected
semen17,18,24,32.
These techniques are currently in widespread use in different parts
of the world29,30,41,43. Some authors, however, question this type of
procedure and raise doubts as to its effectiveness in removing HIV
from sperm1,2,3,37. There are still questions regarding the possible passive
transport of the virus from the systemic compartment to the genital
tract23. Several studies report both a limited relationship between blood
plasma and seminal-HIV viral load, as well as the presence of
phylogenetically different strains in both. They also report possible
intermittent excretion of HIV in semen, whereas in blood the viremia
persists during all stages of the disease16, even during HAART27,35.
Nevertheless, a small fraction of HIV carriers remain asymptomatic
after years of infection, with a CD4+ cell count of over 500 mm3 and
undetectable viral load, even without any treatment4,6,10,46. These patients
are designated long-term nonprogressors (LTNPs)7.
The risk of hepatitis C transmission in assisted reproduction
techniques is currently the subject of widespread debate11,22,33.  LEVY
et al. investigated the presence of HCV RNA in the semen of infected
men in order to find out if semen fractions act as a reservoir for the
hepatitis C virus. In their study, HCV RNA was found in 2/39 (5%) of
semen and semen fraction samples, giving direct evidence of the risk
of contamination that may exist in human reproduction techniques22.
Other studies concluded that although the presence of HCV in semen
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is intermittent31 and not common13,15, sexual transmission cannot be
ruled out20,34.
 In contrast, both recent and earlier studies concluded that
purification of motile spermatozoa by either the discontinuous gradient
or swim-up method, or even by a combination of these techniques,
reduces the number of HIV and/or HCV particles in semen to
undetectable levels8,14,17,18,24,28,32, making it possible for serodiscordant
couples to conceive a child by means of assisted reproduction techniques
with minimum risk of seroconversion14,15,32.
Although there are a large number of studies regarding the
transmission of HIV and/or HCV through assisted reproduction
techniques, the findings differ and are to a certain extent in conflict
with each other, thus reinforcing the need for further investigation using
molecular biology tests.
OBJECTIVE
This study set out to evaluate the effectiveness of density gradient
centrifugation and swim-up techniques in reducing HIV and HCV loads
in infected semen, using molecular biology tests for viral detection.
MATERIAL AND METHODS
1. Population selection: Between January 2003 and May 2004,
semen was collected from a convenience sample of 20 HIV/HCV-
coinfected patients in the 27- to 45-year age range who had undetectable
plasma viral loads for HIV, were positive for HCV RNA in blood (by
RT- PCR) and for anti-HCV (by ELISA), and who had presented at the
Human Reproduction Section of the Federal University of São Paulo
for assisted reproduction screening. Patients who had undergone
vasectomy, had azoospermia or referred a symptomatic Sexually
Transmitted Disease (STD) at enrolment were excluded from the study.
The investigation protocol was approved by the Institutional Review
Board.
2. Semen collection and processing: Samples were collected by
masturbation into a sterile polypropylene flask after three to five days
of ejaculatory abstinence. After liquefaction and homogenization, the
seminal sample was divided into two aliquots. The first aliquot was
initially submitted to semen analysis according to the World Health
Organization (WHO) guidelines48. Following semen analysis, the
aliquot was submitted to semen processing using a discontinuous
Percoll® (Pharmacia, Sweden) gradient technique at two different
concentrations (90% and 45%). After centrifugation (110 g, 30
minutes), three different fractions were obtained: seminal plasma, dead
sperm and cellular elements other than sperm (germ line cells, cellular
debris, bacteria and leukocytes), and motile spermatozoa.
The second aliquot (total semen) was stored in a -70 ºC freezer
and used later in parallel with seminal fractions in our search for HCV
and HIV genital shedding. For this purpose, 100 µL of total semen and
of the three fractions obtained by the discontinuous gradient technique
were used for RT PCR multiplex amplification of HCV and HIV
sequences before semen washing.
The remaining volume of each fraction (approximately 900 µL)
was washed three times with RPMI and the cell pellet resuspended in
1 mL of medium. The fraction containing motile spermatozoa was
further submitted to the swim-up method26. The best motile sperm that
migrated to the culture medium were then carefully removed.
All samples (positive control, total semen and seminal fractions)
were then submitted to nucleic acid extraction using the Nuclisens®
kit (Biomérieux, Brazil) according to the manufacturer’s instructions.
Nucleic acids were eluted in 50 µL of a specific buffer9 and stored
at -70 ºC until qualitative pre- and post-semen-washing RT-PCR viral-
sequence amplification was performed. This test was carried out using
100 µL of each pre- and post-semen washing aliquot.
3. HIV and HCV Multiplex RT-PCR
3.1 cDNA synthesis: Complementary DNA (cDNA) was
synthesized using a reaction mixture that contained 1x RT Buffer, 0.2





103M DTT, 2.5 µM, PDN(6) 2.5U, M-MLV RT and 22.0 µL of extracted
RNA in a total volume of 40 µL, following a standardized protocol
(65 ºC for five min, 22 ºC for 10 min, 37 ºC for 30 min and 95 ºC for
five min).
3.2 HIV/HCV Multiplex RT-PCR: Ten microlitres of cDNA were
then submitted to a qualitative multiplex RT-PCR technique, in which
three viral genome sequences (HIV38, HCV and Dengue type 1 virus)
were simultaneously amplified using specific primer pairs for each
viral agent.
Multiplex RT-PCR amplification was performed in total semen as
well as in the spermatozoa and dead-sperm and nonspermatozoa
seminal fractions using a reaction mixture that contained 1x Buffer,





of AmpliTaq Gold® (Applied Biosystems, Foster City, Ca, USA) in
40 µL total volume. The following amplification protocol was used:
one cycle at 95 °C for five minutes followed by 40 cycles consisting of
Table 1
Specific primer pairs used for multiplex RT-PCR amplification of viral genome sequences in seminal samples
HIV RAR 1032 5’GAG ACA CCA GGA ATT AGA TAT CAG TAC AAT GT3’
RAR 1033 5’CTA AAT CAG ATC CTA CAT ATA AGT CAT CAT GT3’
HCV SM3 5’CTA GCC ATG GCG TTA GAT3’
HC18 5’GGT GCA CGG TCT ACG AGA CCT3’
Dengue D1 5’ TCA ATA TGC TGA AAC GCG GGA GAA ACC G3’
TS1 5’CGT CTC AGT GAT CCG GGG G3’
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30 seconds at 94 °C, 30 seconds at 55 °C and one minute at 65 °C, and
a final 7-minute extension at 65 °C in an automated thermal cycler.
To validate the nucleid-acid extraction and the RT-PCR
amplification steps, 10 µL of serum known to be infected by the Dengue
I virus were added to each sample as an internal reaction control. We
used a 100 µL mix containing 10 µL of HCV-positive (774,892 viral
copies/mL) and 10 µL of HIV-positive (1,700,000 viral copies/mL)
sera, 10 µL of Dengue I virus culture supernatant and 70 µL of HCV,
HIV and dengue-negative serum as a positive control for the HIV/
HCV multiplex RT-PCR reaction. Analytic sensitivity is 500 UI/mL
for both viruses (José Eduardo Levi, personal communication).
After electrophoresis, RT-PCR amplification products were
visualized under ultraviolet light on 2% agarose gels stained with
ethidium bromide.
RESULTS
Each patient provided one seminal sample that was used for seven
different HIV/HCV multiplex RT-PCR tests (total semen in the pre-
washing phase; seminal pre and post-washing phases). A total of 140
multiplex RT-PCR reactions were performed on semen samples
collected from twenty HIV/HCV-coinfected patients.
In the pre-washing phase HIV RNA was detected in 100% of total-
semen samples, as well as in 50% of seminal plasma samples. HIV-
RNA sequences were detected in dead-sperm and non-sperm cells from
six out of twenty cases (30%) and in motile-spermatozoa fractions in
one out of twenty cases (5%). In contrast, HCV RNA was detected in
only one of the 20 total-semen specimens tested.
After semen washing, neither HIV RNA nor HCV RNA could be
detected in any of seminal fractions. However, Dengue virus sequences
were detected in all specimens, confirming the efficiency of the
extraction, reverse-transcription and PCR-amplification steps.
DISCUSSION
HIV and HCV share the same transmission pathways (parenteral
and sexual), and there is therefore an increased risk of coinfection,
especially as the hepatitis C virus is ten times more infectious than
HIV. HIV/HCV coinfection is a serious public health problem
worldwide, and 30% of people infected with HIV are also coinfected
with HCV39. There is evidence that this coinfection can change the
natural history of HIV/AIDS infection by causing the number of TCD4
+
blood cells to decrease faster, as HCV leads to proliferation of TCD4
+
cells in hepatic tissue and promotes HIV replication39. This would
especially be the case in patients with high HCV titer, due to interference
in the production of cellular cytokines, causing the HIV/HCV viral
load to increase even further47.
Fig. 1 - Flowchart of protocol design using multiplex PCR before and after semen washing.
Fig. 2 - Representative sample of multiplex RT-PCR amplification of HIV and HCV genome
sequence in seminal samples from Brazilian coinfected patients.
Fig. 3 - Flowchart of outcomes for detection and reduction of HIV and HCV in semen from
coinfected patients before and after semen washing.
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The advent of HAART, however, is also changing the natural history
of HIV/HCV coinfection because of increased patient survival15. As a
result, an ever increasing number of serodiscordant couples wish to
have their own child without resorting to gamete donation in sperm
banks or giving up safe sex. The only option available to these couples
is to seek assisted reproduction techniques associated with ultrasensitive
molecular biology tests that ensure that their partner will not be
contaminated or that the virus will not be transmitted horizontally or
vertically.
Some studies suggest that the presence of HIV is an important
cofactor in increased sexual transmission of HCV5,12. The probability
of vertical transmission in female coinfected patients is always higher50
and is always associated with high viral load44.
In our study, HCV RNA was detected in the pre-semen washing
phase in only one sample of total semen, suggesting that sexual
transmission can occur, but that it is less frequent than HIV. These
findings agree with data in the literature, where HCV was rarely detected
in semen12, and then only intermittently31.
In contrast, there was a 100% prevalence of HIV RNA in total
semen. This positivity rate confirms both the high degree of sensitivity
of our multiplex PCR and the effectiveness of the HIV/HCV RNA
extraction method, which eliminates possible inhibitors that could
produce false-negative results.
Because our casuistic only includes patients with undetectable
plasma viral load for HIV, the high prevalence of HIV RNA found in
total semen can be explained by HIV compartmentalization16,36,44, as
we had expected HIV not to be detected in at least some semen samples.
The fact that we found HIV in seminal plasma and in dead-sperm
and non-sperm cells in 50% and 30% of the samples respectively
suggests that seminal plasma and nonsperm cells are more infected by
HIV than spermatozoa. This finding may be related to the frequent
presence of polymorphonuclear leukocytes in this fraction. These cells
are considered a risk factor for excretion of HIV in semen, as they are
related to inflammation and infection and involve other cells such as
macrophages and lymphocytes, which are known to be HIV carriers8.
Our findings confirm the evidence of earlier studies, and in
particular that carried out by KIM et al.18. While investigating the
possibility of spermatozoa infection by HIV by means of specific
receptors (CD4, CCR5, CXCR4), KIM et al. observed that the presence
of the virus is limited to seminal plasma and nonsperm cells, and
concluded that HIV does not target sperm cells.
In the post-semen washing phase, however, virus detection proved
negative in all the fractions. The overall effectiveness of semen washing
and Percoll® followed by swim-up observed in our results corroborates
data from the literature, in which two methods were also used together
to obtain sperm cells without viral particles8,17,18,32,41,43. The effectiveness
of these techniques is complemented by molecular biology methods
which are indispensable in assisted reproduction programs for
serodiscordant couples14,19,42.
We conclude that semen washing, together with the relevant
reproductive technology and HAART, reduce the risk of viral
transmission. These findings lead us to believe that, although semen is
rarely found to contain HCV, semen purification is highly beneficial
for HIV/HCV coinfected individuals.
RESUMO
Detecção do RNA do HIV e HCV em sêmen de homens
brasileiros, usando PCR multiplex antes e depois do “semen
washing”
O aumento da sobrevida dos pacientes que utilizam terapêutica
antiretroviral altamente eficaz (HAART- Highly Active Antiretroviral
Therapy) trouxe uma nova demanda de casais sorodiscordantes que
desejam filhos. Como esses casais não podem abandonar o uso de
preservativos, torna-se indispensável tratar o sêmen infectado com
técnicas laboratoriais eficazes que além de isolar os melhores
espermatozóides, reduzam a carga viral do HIV e HCV a níveis
indetectáveis.
Para isso, são utilizadas técnicas de semen washing, associadas a
testes ultra sensíveis de biologia molecular. Após análise seminal,
sêmen de 20 pacientes co-infectados HIV-HCV foram submetidos a
fracionamento celular e isolamento de espermatozóides móveis através
de método de densidade de gradiente descontínuo e swim-up.
Posteriormente, testes para detecção do RNA do HIV e HCV foram
aplicados nos sêmens totais e frações seminais obtidas. Em fase pré
semen washing, o HIV foi detectado em 100% dos semens totais.
Contrariamente, o HCV foi detectado em apenas uma amostra. Em
fase pós semen washing, o HIV e HCV não foram detectados em
nenhuma das frações seminais. A redução do HIV e do HCV através
de semen washing mostra-se um método eficaz a indivíduos co-
infectados HIV-HCV, apesar do encontro do HCV no sêmen ser raro.
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